Top Markets
Coin of the day
Captor Therapeutics Spolka Akcyjna Captor Therapeutics Spolka Akcyjna

Captor Therapeutics Spolka Akcyjna

CTX
Classifica tra le azioni #20515
Captor Therapeutics Spolka Akcyjna, a biopharmaceutical company, focuses on the... Captor Therapeutics Spolka Akcyjna, a biopharmaceutical company, focuses on the discovery and development of protein degradation drugs for cancer and autoimmune diseases. The company provides Targeted Protein Degradation technology that overcomes many existing drug limitations by removing proteins resistant to available therapeutics. Its products in various stages of development include CT-03, which has completed the Phase 1 clinical trials for the treatment of non-small cell lung cancer, triple-negative breast cancer, as well as cancers of the blood, lymphatic system, and bone marrow; and CT-01, which also completed the Phase 1 clinical trials for the treatment of hepatocellular carcinoma, through degradation of oncofetal transcription factor. The company was incorporated in 2015 and is headquartered in Wroclaw, Poland.
Prezzo delle azioni
$20.38
Capitalizzazione di mercato
$129.09M
Variazione (1 giorno)
-0.82%
Variazione (1 anno)
80.91%
Paese
PL
Scambia Captor Therapeutics Spolka Akcyjna (CTX)

Categoria

Cronologia dei frazionamenti azionari per Captor Therapeutics Spolka Akcyjna (CTX)
L’azione Captor Therapeutics Spolka Akcyjna (simbolo: CTX) ha subito un totale di 0 frazionamenti.
L’ultimo frazionamento è avvenuto il Aug 24, 2026.
Una quota di CTX acquistata prima di Aug 24, 2026 equivale oggi a 0 quote di CTX.
Elenco dei frazionamenti azionari
Anno Frazionamento Moltiplicatore Moltiplicatore cumulativo
Non abbastanza dati per le date fornite.
Frazionamenti azionari di aziende simili o concorrenti
Azienda Numero di frazionamenti azionari Moltiplicatore cumulativo Il paese
1 x2
US
0 -
NL
0 -
US
1 x3
AU
0 -
CH